IMI consortium funds research into drug effectiveness

01/28/2013 | BioOptics World

Researchers funded by a consortium of pharmaceutical companies and Europe's Innovative Medicines Initiative are using advanced laser technology to identify how drug molecules interact with protein receptors in order to develop more effective medicines. Scientists at the University of Nottingham in the U.K. are looking at how compounds attach to cells' surface proteins and will explore the relationship between effectiveness and length of time spent bound to the cell.

View Full Article in:

BioOptics World

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY